Literature DB >> 12646700

Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells.

Roberta Castriconi1, Claudia Cantoni, Mariella Della Chiesa, Massimo Vitale, Emanuela Marcenaro, Romana Conte, Roberto Biassoni, Cristina Bottino, Lorenzo Moretta, Alessandro Moretta.   

Abstract

The surface density of the triggering receptors responsible for the natural killer (NK)-mediated cytotoxicity is crucial for the ability of NK cells to kill susceptible target cells. In this study, we show that transforming growth factor beta1 (TGFbeta1) down-regulates the surface expression of NKp30 and in part of NKG2D but not that of other triggering receptors such as NKp46. The TGFbeta1-mediated inhibition of NKp30 surface expression reflects gene regulation at the transcriptional level. NKp30 has been shown to represent the major receptor involved in the NK-mediated killing of dendritic cells. Accordingly, the TGFbeta1-dependent down-regulation of NKp30 expression profoundly inhibited the NK-mediated killing of dendritic cells. On the contrary, killing of different NK-susceptible tumor cell lines was variably affected, reflecting the differential usage of NKp30 and/or NKG2D in the lysis of such tumors. Our present data suggest a possible mechanism by which TGFbeta1-producing dendritic cells may acquire resistance to the NK-mediated attack.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12646700      PMCID: PMC153058          DOI: 10.1073/pnas.0730640100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Recognition of autologous dendritic cells by human NK cells.

Authors:  E Carbone; G Terrazzano; G Ruggiero; D Zanzi; A Ottaiano; C Manzo; K Kärre; S Zappacosta
Journal:  Eur J Immunol       Date:  1999-12       Impact factor: 5.532

Review 2.  Natural cytotoxicity receptors that trigger human NK-cell-mediated cytolysis.

Authors:  A Moretta; R Biassoni; C Bottino; M C Mingari; L Moretta
Journal:  Immunol Today       Date:  2000-05

3.  Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire.

Authors:  J J Campbell; S Qin; D Unutmaz; D Soler; K E Murphy; M R Hodge; L Wu; E C Butcher
Journal:  J Immunol       Date:  2001-06-01       Impact factor: 5.422

Review 4.  Regulation of immune responses through inhibitory receptors.

Authors:  E O Long
Journal:  Annu Rev Immunol       Date:  1999       Impact factor: 28.527

Review 5.  Interleukin-10 and the interleukin-10 receptor.

Authors:  K W Moore; R de Waal Malefyt; R L Coffman; A O'Garra
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

6.  Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin.

Authors:  D Pende; C Cantoni; P Rivera; M Vitale; R Castriconi; S Marcenaro; M Nanni; R Biassoni; C Bottino; A Moretta; L Moretta
Journal:  Eur J Immunol       Date:  2001-04       Impact factor: 5.532

7.  Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA.

Authors:  S Bauer; V Groh; J Wu; A Steinle; J H Phillips; L L Lanier; T Spies
Journal:  Science       Date:  1999-07-30       Impact factor: 47.728

8.  NK cell-mediated lysis of autologous antigen-presenting cells is triggered by the engagement of the phosphatidylinositol 3-kinase upon ligation of the natural cytotoxicity receptors NKp30 and NKp46.

Authors:  G M Spaggiari; R Carosio; D Pende; S Marcenaro; P Rivera; M R Zocchi; L Moretta; A Poggi
Journal:  Eur J Immunol       Date:  2001-06       Impact factor: 5.532

Review 9.  Role of transforming growth factor beta in cancer.

Authors:  B Pasche
Journal:  J Cell Physiol       Date:  2001-02       Impact factor: 6.384

Review 10.  Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.

Authors:  A Moretta; C Bottino; M Vitale; D Pende; C Cantoni; M C Mingari; R Biassoni; L Moretta
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

View more
  228 in total

Review 1.  TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression.

Authors:  Li Yang; Yanli Pang; Harold L Moses
Journal:  Trends Immunol       Date:  2010-06-01       Impact factor: 16.687

2.  IRX-2, a novel immunotherapeutic, enhances and protects NK-cell functions in cancer patients.

Authors:  B Schilling; E S Halstead; P Schuler; M Harasymczuk; J E Egan; T L Whiteside
Journal:  Cancer Immunol Immunother       Date:  2012-01-20       Impact factor: 6.968

3.  Effects of prolactin and cortisol on natural killer (NK) cell surface expression and function of human natural cytotoxicity receptors (NKp46, NKp44 and NKp30).

Authors:  E Mavoungou; M K Bouyou-Akotet; P G Kremsner
Journal:  Clin Exp Immunol       Date:  2005-02       Impact factor: 4.330

Review 4.  NKG2D in NK and T cell-mediated immunity.

Authors:  Kouetsu Ogasawara; Lewis L Lanier
Journal:  J Clin Immunol       Date:  2005-11       Impact factor: 8.317

5.  Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C.

Authors:  J Nattermann; G Feldmann; G Ahlenstiel; B Langhans; T Sauerbruch; U Spengler
Journal:  Gut       Date:  2005-12-01       Impact factor: 23.059

6.  TGFβR1 Blockade with Galunisertib (LY2157299) Enhances Anti-Neuroblastoma Activity of the Anti-GD2 Antibody Dinutuximab (ch14.18) with Natural Killer Cells.

Authors:  Hung C Tran; Zesheng Wan; Michael A Sheard; Jianping Sun; Jeremy R Jackson; Jemily Malvar; Yibing Xu; Larry Wang; Richard Sposto; Eugene S Kim; Shahab Asgharzadeh; Robert C Seeger
Journal:  Clin Cancer Res       Date:  2016-10-10       Impact factor: 12.531

Review 7.  Transforming growth factor beta (TGF-beta) and inflammation in cancer.

Authors:  Brian Bierie; Harold L Moses
Journal:  Cytokine Growth Factor Rev       Date:  2009-12-16       Impact factor: 7.638

8.  Differential mechanisms of shedding of the glycosylphosphatidylinositol (GPI)-anchored NKG2D ligands.

Authors:  Lola Fernández-Messina; Omodele Ashiru; Philippe Boutet; Sonia Agüera-González; Jeremy N Skepper; Hugh T Reyburn; Mar Valés-Gómez
Journal:  J Biol Chem       Date:  2010-01-14       Impact factor: 5.157

9.  MHC class I chain-related protein A antibodies and shedding are associated with the progression of multiple myeloma.

Authors:  Masahisa Jinushi; Matthew Vanneman; Nikhil C Munshi; Yu-Tzu Tai; Rao H Prabhala; Jerome Ritz; Donna Neuberg; Kenneth C Anderson; Daniel Ruben Carrasco; Glenn Dranoff
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-17       Impact factor: 11.205

10.  Shaping of NK cell responses by the tumor microenvironment.

Authors:  Ana Stojanovic; Margareta P Correia; Adelheid Cerwenka
Journal:  Cancer Microenviron       Date:  2012-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.